Tenderwize
Back to tender search

Open House Discount Contracts for Tofacitinib, ATC L04AF01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 196 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tofacitinib , ATC L04AF01

25/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

25 / 100

Complexity

20 / 100

Risk factors

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Tofacitinib (ATC L04AF01)
  • Open house model: any qualifying pharmaceutical company can join at any time
Show full summary

AOK Rheinland-Pfalz/Saarland is offering non-exclusive discount contracts for the active substance Tofacitinib (ATC L04AF01) under an open house model. All interested pharmaceutical companies can join by submitting required documents. Contracts run from May 2025 to April 2027, with possible monthly entry. No estimated value is provided. The procedure is explicitly stated not to be a public procurement under EU directives.

Risks

No estimated value or volume provided; actual business may be negligible.

Buyer reserves the right to replace open house contracts with exclusive contracts, automatically terminating open house...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company with authorized and marketable medicines in Germany
  • Medicines must be listed in Lauer-Taxe or proven via AMIce database extracts

Administrative

  • Submit signed contract documents by specified deadlines for desired start date

Requirements may be incomplete.

Buyer

Lots (1)

LOT-0001

Open House Discount Contracts for Tofacitinib, ATC L04AF01

Non-exclusive discount contracts for Tofacitinib under an open house model. All interested pharmaceutical companies can enter at any time during the 24-month period. Contracts are non-negotiable, standard terms. Early termination possible if exclusive contracts are concluded.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

Apr 2025 - Apr 2027

Category

Pharmaceutical products

Procurement Details

Publication date
12 Mar 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
164834-2025

Documents (1)

Similar tenders